A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute lower GI GVHD Meeting Abstract
| Authors: | Ponce, D.; Alousi, A.; Nakamura, R.; Sandhu, K.; Barker, J.; Shia, J.; Yan, X.; Daley, W.; Moore, G.; Fatmi, S.; Soto, C.; Gomes, A.; Slingerland, J.; Giardina, P.; Peled, J.; van den Brink, M.; Hanash, A. |
| Abstract Title: | A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute lower GI GVHD |
| Meeting Title: | 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 55 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Aug 29-Sept 1 |
| Meeting Location: | Virtual |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2020-12-11 |
| Start Page: | 80 |
| End Page: | 81 |
| Language: | English |
| ACCESSION: | WOS:000600556200070 |
| PROVIDER: | wos |
| PMCID: | PMC7729707 |
| PUBMED: | 33311610 |
| DOI: | 10.1038/s41409-020-01119-3 |
| Notes: | Meeting Abstract: O069 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work